Cargando…
Effect of HLA on Hepatitis C Virus Clearance and Persistence in Anti-HCV-positive End-stage Renal Disease Patients
BACKGROUND/AIMS: The efficacy of immune response against hepatitis C virus (HCV) is determined by human leukocyte antigen (HLA) molecules of the host which present HCV antigens to CD4 + and CD8 + T lymphocytes. In this study, we aimed to investigate the possible relationship between the frequencies...
Autores principales: | Ocal, Serkan, Selcuk, Haldun, Korkmaz, Murat, Altun, Reskan, Yildirim, Abdullah E., Akbas, Enver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067914/ https://www.ncbi.nlm.nih.gov/pubmed/24976281 http://dx.doi.org/10.4103/1319-3767.133007 |
Ejemplares similares
-
Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
por: Altun, Reskan, et al.
Publicado: (2015) -
The safety and efficacy of ERCP in the pediatric population with standard scopes: Does size really matter?
por: Yıldırım, Abdullah Emre, et al.
Publicado: (2016) -
Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark
por: Mumdzhiev, Nikola Hristov, et al.
Publicado: (2019) -
Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure
por: Hwang, Jyh-Chang, et al.
Publicado: (2016) -
Renal transplant improves pulmonary hypertension in patients with end stage renal disease
por: Bozbas, Serife Savas, et al.
Publicado: (2011)